Page 2 of 39 · 913 questions tagged clinical-trials.
Numbers first: SURPASS-2 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I am asking about the protocol logic rather than about my own case specifically. I would like to know whether this claim survives contact with evidence. If the answer…
For reference: SURMOUNT-OSA · 60 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
Details up front: STEP 5 · 10 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
What I have: a GLP-1 receptor agonist · STEP 2. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I…
Details up front: vomiting · retatrutide · PIONEER-1. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I want to know whether this is a real physical effect or…
Details up front: SURMOUNT-2 · dulaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
Concretely: survodutide · room temperature. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Is…
Conditions: ATTAIN-1 · tirzepatide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs…
What I am working with: 5 mg · cagrilintide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
Conditions: SURMOUNT-OSA · 2 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
What I am working with: headache · a GLP-1 receptor agonist · TRIUMPH-1. I have read the primary source rather than the summary, which has left me with more…
Stated plainly: SURMOUNT-5 · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do…
Stated plainly: early satiety · cagrilintide · SURPASS-2. I have read the primary source rather than the summary, which has left me with more questions. I understand…
For reference: SURMOUNT-OSA · hair thinning · 30 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…
Stated plainly: dulaglutide · semaglutide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
The particulars: tirzepatide · SURPASS-2. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…
The particulars: SURMOUNT-3 · semaglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
I have the full paper rather than the abstract, and the supplementary appendix. I understand the observation; what I do not understand is the mechanism behind it. I…
Numbers first: FLOW · retatrutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Numbers first: SURMOUNT-3 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Numbers first: cagrilintide · SURMOUNT-2. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
For reference: 15 mg · ecnoglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than on…